Pravastatin-associated	pravastatin-associated	O	O
myopathy	myopathy	O	S_disease
.	.	O	O

Report	report	O	O
of	of	O	O
a	a	O	O
case	case	O	O
.	.	O	O

A	a	O	O
case	case	O	O
of	of	O	O
acute	acute	O	B_disease
inflammatory	inflammatory	O	B_disease
myopathy	myopathy	O	S_disease
associated	associated	O	O
with	with	O	O
the	the	O	O
use	use	O	O
of	of	O	O
pravastatin	pravastatin	S_chemicals	O
,	,	O	O
a	a	O	O
new	new	O	O
hydrophilic	hydrophilic	O	O
3-hydroxy-3	3-hydroxy-3	O	O
methylglutaril	methylglutaril	O	O
coenzyme	coenzyme	B_chemicals	O
A	a	I_chemicals	O
reductase	reductase	B_chemicals	O
inhibitor	inhibitor	I_chemicals	O
,	,	O	O
is	is	O	O
reported	reported	O	O
.	.	O	O

The	the	O	O
patient	patient	O	O
,	,	O	O
a	a	O	O
69-year-old	69-year-old	O	O
man	man	O	O
was	was	O	O
affected	affected	O	O
by	by	O	O
non-insulin-dependent	non-insulin-dependent	O	B_disease
diabetes	diabetes	O	B_disease
mellitus	mellitus	O	I_disease
and	and	O	O
hypertension	hypertension	O	S_disease
.	.	O	O

He	he	O	O
assumed	assumed	O	O
pravastatin	pravastatin	S_chemicals	O
(	(	O	O
20	20	O	O
mg/day	mg/day	O	O
)	)	O	O
because	because	O	O
of	of	O	O
hypercholesterolemia	hypercholesterolemia	O	S_disease
.	.	O	O

He	he	O	O
was	was	O	O
admitted	admitted	O	O
with	with	O	O
acute	acute	O	O
myopathy	myopathy	O	S_disease
of	of	O	O
the	the	O	O
lower	lower	O	B_disease
limbs	limbs	O	I_disease
which	which	O	O
resolved	resolved	O	O
in	in	O	O
a	a	O	O
few	few	O	O
days	days	O	O
after	after	O	O
pravastatin	pravastatin	S_chemicals	O
discontinuation	discontinuation	O	O
.	.	O	O

A	a	O	O
previously	previously	O	O
unknown	unknown	O	O
hypothyroidism	hypothyroidism	O	S_disease
,	,	O	O
probably	probably	O	O
due	due	O	O
to	to	O	O
chronic	chronic	O	B_disease
autoimmune	autoimmune	O	B_disease
thyroiditis	thyroiditis	O	S_disease
,	,	O	O
was	was	O	O
evidenced	evidenced	O	O
.	.	O	O

Muscle	muscle	O	O
biopsy	biopsy	O	O
(	(	O	O
left	left	O	O
gastrocnemius	gastrocnemius	O	O
)	)	O	O
revealed	revealed	O	O
a	a	O	O
perimysial	perimysial	O	O
and	and	O	O
endomysial	endomysial	O	O
inflammatory	inflammatory	O	O
infiltrate	infiltrate	O	O
with	with	O	O
a	a	O	O
prevalence	prevalence	O	O
of	of	O	O
CD4	cd4	O	B_disease
+	+	O	I_disease
lymphocytes	lymphocytes	O	O
.	.	O	O

While	while	O	O
lovastatin	lovastatin	S_chemicals	O
and	and	O	O
simvastatin	simvastatin	O	O
have	have	O	O
been	been	O	O
associated	associated	O	O
with	with	O	O
toxic	toxic	O	B_disease
myopathy	myopathy	O	S_disease
,	,	O	O
pravastatin-associated	pravastatin-associated	O	O
myopathy	myopathy	O	S_disease
could	could	O	O
represent	represent	O	O
a	a	O	O
distinct	distinct	O	O
,	,	O	O
inflammatory	inflammatory	O	O
entity	entity	O	O
.	.	O	O

